liu.seSearch for publications in DiVA
Change search
ReferencesLink to record
Permanent link

Direct link
Homeopathy: meta-analyses of pooled clinical data.
Linköping University, Faculty of Health Sciences. Linköping University, Department of Medical and Health Sciences, Division of Drug Research. Research Unit, Södertälje Hospital, Södertälje, Sweden.
2013 (English)In: Forschende Komplementärmedizin (2006), ISSN 1661-4127, Vol. 20, no 5, 376-381 p.Article in journal (Refereed) Published
Abstract [en]

In the first decade of the evidence-based era, which began in the mid-1990s, meta-analyses were used to scrutinize homeopathy for evidence of beneficial effects in medical conditions. In this review, meta-analyses including pooled data from placebo-controlled clinical trials of homeopathy and the aftermath in the form of debate articles were analyzed. In 1997 Klaus Linde and co-workers identified 89 clinical trials that showed an overall odds ratio of 2.45 in favor of homeopathy over placebo. There was a trend toward smaller benefit from studies of the highest quality, but the 10 trials with the highest Jadad score still showed homeopathy had a statistically significant effect. These results challenged academics to perform alternative analyses that, to demonstrate the lack of effect, relied on extensive exclusion of studies, often to the degree that conclusions were based on only 5-10% of the material, or on virtual data. The ultimate argument against homeopathy is the 'funnel plot' published by Aijing Shang's research group in 2005. However, the funnel plot is flawed when applied to a mixture of diseases, because studies with expected strong treatments effects are, for ethical reasons, powered lower than studies with expected weak or unclear treatment effects. To conclude that homeopathy lacks clinical effect, more than 90% of the available clinical trials had to be disregarded. Alternatively, flawed statistical methods had to be applied. Future meta-analyses should focus on the use of homeopathy in specific diseases or groups of diseases instead of pooling data from all clinical trials. © 2013 S. Karger GmbH, Freiburg.

Place, publisher, year, edition, pages
2013. Vol. 20, no 5, 376-381 p.
National Category
Medical and Health Sciences
URN: urn:nbn:se:liu:diva-102531DOI: 10.1159/000355916ISI: 000327462600010PubMedID: 24200828OAI: diva2:678851
Available from: 2013-12-13 Created: 2013-12-13 Last updated: 2014-01-07

Open Access in DiVA

No full text

Other links

Publisher's full textPubMed

Search in DiVA

By author/editor
Hahn, Robert G
By organisation
Faculty of Health SciencesDivision of Drug Research
Medical and Health Sciences

Search outside of DiVA

GoogleGoogle Scholar
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

Altmetric score

Total: 53 hits
ReferencesLink to record
Permanent link

Direct link